MedPath
TGA Approval

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial (282729)

282729

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial

Merck Healthcare Pty Ltd

January 3, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/740fd0ffe4957283c633e507012fc32f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b87aeab0805a1ad163a892f7c891039f.pdf

Active Ingredients

avelumab

© Copyright 2025. All Rights Reserved by MedPath
BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial (282729) - TGA 批准文号 | MedPath